Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversiti Sains Malaysia

About this trial

International travel disrupts gut health through dietary changes, microbial exposure, and stress, often causing gastrointestinal symptoms like traveler's diarrhea and sleep disturbances. These shifts may increase antibiotic resistance risks. Probiotics may help stabilize gut microbiota and improve well-being during travel. This randomized, double-blind, placebo-controlled trial investigated whether probiotic supplementation mitigates gut microbiota perturbations, gastrointestinal symptoms, and sleep issues in adults traveling abroad. The investigators also assessed changes in anxiety, well-being, gut immunity, microbial function, and antibiotic resistance genes.

Eligibility criteria

Qualifiers

Generally healthy adults

Scheduled to undertake a short-term round trip (less than 7 days) to abroad

Able to complete study procedures

Willing to take intervention products

Disqualifiers

Use of antibiotics, probiotics, hormones, immunosuppressants, biologics or JAK inhibitors within four weeks prior to study

Chronic or severe systemic diseases (including cardiovascular, hepatic, renal, malignant or psychiatric disorders)

Uncontrolled parasitic infections

Long-term use of corticosteroids, growth hormone, vitamin B12, lysine or inositol

Trial design

Treatments tested in this trial

  • Probiotic
  • Placebo

Treatment groups

46 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Universiti Sains Malaysia

Lead sponsor

Tsinghua University Science and Technology

Collaborator